RGS10 and Parkinson disease: It can be hypothesized, then, that individuals with chronic inflammatory conditions such as PD might have reduced RGS10 levels in activated immune cells, a condition which could contribute to the potentiation and persistence of proinflammatory responses and increase the likelihood of immune-mediated neurotoxicity.